Gilead Sciences, Inc. - Product Pipeline Review - 2013 - New Report Available

From: Fast Market Research, Inc.
Published: Wed Oct 30 2013


Global Market Direct's pharmaceuticals report, "Gilead Sciences, Inc. - Product Pipeline Review - 2013" provides data on the Gilead Sciences, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Gilead Sciences, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Gilead Sciences, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Gilead Sciences, Inc. - Brief Gilead Sciences, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Gilead Sciences, Inc. human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Gilead Sciences, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Gilead Sciences, Inc.'s pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at
- http://www.fastmr.com/prod/701244_gilead_sciences_inc_product_pipeline_review_2013.aspx?afid=301

Reasons to Get this Report

* Evaluate Gilead Sciences, Inc.'s strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Gilead Sciences, Inc. in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Gilead Sciences, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Gilead Sciences, Inc..
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Gilead Sciences, Inc. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Gilead Sciences, Inc.

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- LG Life Sciences, Ltd. - Product Pipeline Review - 2013
- Gilead Sciences, Inc. (GILD) - Financial and Strategic SWOT Analysis Review
- Bioniche Life Sciences, Inc. - Product Pipeline Review - 2013
- BioDelivery Sciences International, Inc. - Product Pipeline Review - 2013
- Amorfix Life Sciences Ltd. - Product Pipeline Review - 2013

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email: press@fastmr.com
Contact Phone: 1-413-485-7001

Visit website »